Drug Trial Radar · NCT02851407
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Last checked: Nov 20, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
372
Actual
Start
Sep 1, 2016
Primary completion
Oct 20, 2020
Study completion Oct 20, 2020
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Aug 1, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 1 month
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to compare the efficacy and safety of defibrotide prophylaxis in addition to best supportive care versus best supportive care alone in the prevention of hepatic veno- occlusive disease (VOD) in adult and pediatric patients undergoing hematopoietic stem cell transplant who are at high risk or very high risk of developing VOD.
Conditions
- Veno-occlusive Disease
Interventions
DefibrotideDrug
Best Supportive CareOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Veno-occlusive Disease (VOD)-Free Survival by Day +30 Post-Hematopoietic Stem Cell Transplant (HSCT) Per the Independent Endpoint Adjudication Committee (EPAC)Time frame: Day +30 Post-HSCT
Locations
114 sites in 14 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama
Phoenix Children's Hospital
Phoenix, Arizona
University of Arizona Cancer Center
Tucson, Arizona
Children's Hospital Los Angeles
Los Angeles, California
Stanford University
Palo Alto, California
Rady Childrens Hospital San Diego
San Diego, California
University of California San Francisco
San Francisco, California
Colorado Children's Hospital
Aurora, Colorado
Alfred I Dupont Hospital For Children
Wilmington, Delaware
Nicklaus Childrens Hospital
Miami, Florida
Johns Hopkins All Children's Hospital
St. Petersburg, Florida
Children's Healthcare of Atlanta
Atlanta, Georgia
Ann and Robert H Lurie Childrens Hospital of Chicago
Chicago, Illinois
Tufts Floating Hospital for Children
Boston, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts
Children's Hospital of Michigan
Detroit, Michigan
Children's Mercy Hospital
Kansas City, Missouri
Columbia University Medical Center
New York, New York
Weill Cornell Medical College
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Children's Hospital at Montefiore
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
University Hospital Case Medical Center
Cleveland, Ohio
Cleveland Clinic
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Doernbecher Children's Hospital
Portland, Oregon
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Medical University of South Carolina - PPDS
Charleston, South Carolina
Vanderbilt Ingram Cancer Center
Nashville, Tennessee
Children's Medical Center Dallas
Dallas, Texas
Cook Childrens Hospital
Fort Worth, Texas
MD Anderson Cancer Center
Houston, Texas
Texas Childrens Hospital
Houston, Texas
Primary Children's Hospital
Salt Lake City, Utah
Fred Hutchinson Cancer Research Center
Seattle, Washington
Children's Hospital of Wisconsin
Milwaukee, Wisconsin
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Royal Children's Hospital Melbourne
Melbourne, Victoria, Australia
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Showing 40 of 114 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.